Note: Ingredients listed on restricted chemical lists
EC/CAS
203-234-3/104-76-7
Name of the chemical
2-ethyl-1-hexanol
Concentration
1 - 5
General Information
Version
1.1
Revision date
2023-08-17
Product name
EOLYS EXTEND
1.2.1 Relevant identified uses
Professional use
Emergency telephone
32 (0)70.245.245, +33 (0)1.45.42.59.59, +353 1 809 2566, +353 1 809 2166, +356 2545 6508, +966 112324180, +966 112324189, +44 20 7188 7188
Icons in SDS
Company Information
company name
GiPro Srl
e-mail address of the competent person responsible for the Safety Data Sheet
info@gipro.it
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS08
Signal word
Danger
Contains
Hydrocarbons, C11-C13, isoalkanes,<2% aromatics
Hazard statements
H304 - May be fatal if swallowed and enters airways.
Precautionary statements
P262 - Do not get in eyes, on skin, or on clothing. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER, a doctor. P331 - Do NOT induce vomiting. P501 - Dispose of contents/container to a hazardous or special waste collection point.
Supplemental label elements
EUH066 - Repeated exposure may cause skin dryness or cracking.
Additional information
For professional users only.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Iron oxide isostearate (865812-80-2) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
